NFE2L2 and acute myeloid leukemia: We hypothesised that mitochondrial biogenesis and metabolic adaptation induced by the Nrf2-ALDH2 pathway are involved in AML resistance; thus, inhibiting Nrf2-mediated overexpression of ALDH2 may effectively inhibit the growth of AML cells.